首页 > 最新文献

Academic journal of gastroenterology & hepatology最新文献

英文 中文
Trans-Umbilical Laparo-Endoscopic Single Site Surgery with Hepatic Ductoplasty in Management of Childhood Choledochal Cyst: A Single Surgeon Experience with 46 Cases 经脐腹腔镜肝管成形术治疗儿童胆管囊肿46例经验
Pub Date : 2019-09-26 DOI: 10.33552/AJGH.2019.01.000516
T. N. Son, Dinh Duc, D. V. Mai
Aim: To present our techniques and results of trans-umbilical laparo-endoscopic single site surgery (TULESS) with hepatic ductoplasty in the management of childhood choledochal cyst (ChC). Methods: All ChC cases undergoing TULESS excision of ChC, ductoplasty and hepatico-jejunostomy by the same surgeon from October 2012 to October 2017 were reviewed. For TULESS, 3 trocars were placed at a single umbilical skin incision and conventional instruments were used. Results: 46 patients (35 girls, 11 boys) with hepatic ductoplasty were identified from total 237 patients with ChC undergoing TULESS by the same surgeon for the review period. The median age was 17 months. Ductoplasty for a small common hepatic duct (less than 5mm) was carried out in 38 patients and for the presence of an aberrant duct in 8 patients. The median operative time was 195 minutes. There was no intraoperative complication, no conversion to open surgery. Additional trocars (conversion to conventional laparoscopic surgery) were required in just the first case of aberrant duct. Postoperative bile leak was noted in one patient (2.2%), which was resolved with non-operative treatment. The median postoperative hospital stay was 5 days. At a median follow up of 36 months (range: 3 months to 60 months), one patient needed redo surgery for anastomotic stenosis; all other patients were in good health, with excellent postoperative cosmesis. Conclusion: TULESS with conventional instruments is feasible and safe for hepatic ductoplasty for childhood ChC with small common hepatic duct or aberrant duct. Patient’s characteristics, intraoperative findings, operative time and results were analyzed.
目的:介绍经脐腹腔镜内镜下肝管成形术治疗儿童胆总管囊肿(ChC)的技术和结果。方法:回顾性分析2012年10月至2017年10月由同一外科医生进行的所有ChC无管切除、导管成形术和肝空肠造口术的病例。对于TULESS,在单个脐带皮肤切口处放置3个套管针,并使用传统器械。结果:在回顾期内,共有237名ChC患者接受了同一外科医生的TULESS手术,其中46名患者(35名女孩,11名男孩)接受了肝导管成形术。中位年龄为17个月。对38名患者进行了肝总小管(小于5mm)的导管成形术,对8名存在异常导管的患者进行了导管成形术。中位手术时间为195分钟。没有术中并发症,也没有转为开放手术。仅在第一例异常导管病例中,就需要额外的套管针(转为传统腹腔镜手术)。一名患者(2.2%)术后出现胆汁渗漏,通过非手术治疗得以解决。术后平均住院时间为5天。在36个月(范围:3个月至60个月)的中位随访中,一名患者因吻合口狭窄需要再次手术;其他患者健康状况良好,术后美容效果良好。结论:TULESS与常规器械联合应用于儿童先天性肝总管狭窄或肝管异常的肝管成形术是可行且安全的。分析患者的特点、术中表现、手术时间和结果。
{"title":"Trans-Umbilical Laparo-Endoscopic Single Site Surgery with Hepatic Ductoplasty in Management of Childhood Choledochal Cyst: A Single Surgeon Experience with 46 Cases","authors":"T. N. Son, Dinh Duc, D. V. Mai","doi":"10.33552/AJGH.2019.01.000516","DOIUrl":"https://doi.org/10.33552/AJGH.2019.01.000516","url":null,"abstract":"Aim: To present our techniques and results of trans-umbilical laparo-endoscopic single site surgery (TULESS) with hepatic ductoplasty in the management of childhood choledochal cyst (ChC). Methods: All ChC cases undergoing TULESS excision of ChC, ductoplasty and hepatico-jejunostomy by the same surgeon from October 2012 to October 2017 were reviewed. For TULESS, 3 trocars were placed at a single umbilical skin incision and conventional instruments were used. Results: 46 patients (35 girls, 11 boys) with hepatic ductoplasty were identified from total 237 patients with ChC undergoing TULESS by the same surgeon for the review period. The median age was 17 months. Ductoplasty for a small common hepatic duct (less than 5mm) was carried out in 38 patients and for the presence of an aberrant duct in 8 patients. The median operative time was 195 minutes. There was no intraoperative complication, no conversion to open surgery. Additional trocars (conversion to conventional laparoscopic surgery) were required in just the first case of aberrant duct. Postoperative bile leak was noted in one patient (2.2%), which was resolved with non-operative treatment. The median postoperative hospital stay was 5 days. At a median follow up of 36 months (range: 3 months to 60 months), one patient needed redo surgery for anastomotic stenosis; all other patients were in good health, with excellent postoperative cosmesis. Conclusion: TULESS with conventional instruments is feasible and safe for hepatic ductoplasty for childhood ChC with small common hepatic duct or aberrant duct. Patient’s characteristics, intraoperative findings, operative time and results were analyzed.","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46431645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic chylous ascites following vaginal delivery: A Case report 阴道分娩后的特发性乳糜腹水:1例报告
Pub Date : 2019-09-24 DOI: 10.33552/ajgh.2019.01.000515
E. Arslan
License AJGH.MS.ID.000515. Abstract Chylous ascites is described as accumulation of chyle in the abdominal cavity. It has several causes like pancreatitis and tuberculosis. Pregnancies those were complicated by chylous ascites were shown in the literature due to that well known causes. By that time there were not any cases that showed vaginal delivery complicated by incidental chylous ascites. In the present study we reported a 19 year-old women who had chylous ascites after vaginal delivery without any potential causes of the disease. She was consultated by general surgeon and explorative laparotomy was decided which did not show any etiologic reason for ascites. After all she was referred to us for further investigation and treatment of the chyle. She was treated conservatively and the drain was removed on post-op 6th. Despite the detailed investigation there was not found any causes that explain the ascites and the increased intra-abdominal pressure during second stage of delivery was thought to be most potential cause of chylous ascites. Patient was discharged on post-op 10 and on long follow up of 6 and 12 months after delivery she was doing well and had
AJGH许可证。MS.ID.000515摘要乳糜性腹水被描述为腹腔内的乳糜积聚。它有多种病因,如胰腺炎和肺结核。由于众所周知的原因,文献中显示了并发乳糜腹水的妊娠。到那时,还没有任何病例显示阴道分娩并发乳糜性腹水。在本研究中,我们报告了一名19岁的女性,她在阴道分娩后出现乳糜腹水,没有任何潜在的病因。她接受了普通外科医生的咨询,并决定进行剖腹探查,但没有显示出腹水的任何病因。毕竟,她被转诊到我们那里进行乳糜的进一步调查和治疗。她接受了保守治疗,并在第6次手术后取出了引流管。尽管进行了详细的调查,但没有发现任何原因可以解释腹水,第二阶段分娩时腹腔内压力增加被认为是乳糜性腹水的最潜在原因。患者在第10次手术后出院,经过产后6个月和12个月的长期随访,情况良好
{"title":"Idiopathic chylous ascites following vaginal delivery: A Case report","authors":"E. Arslan","doi":"10.33552/ajgh.2019.01.000515","DOIUrl":"https://doi.org/10.33552/ajgh.2019.01.000515","url":null,"abstract":"License AJGH.MS.ID.000515. Abstract Chylous ascites is described as accumulation of chyle in the abdominal cavity. It has several causes like pancreatitis and tuberculosis. Pregnancies those were complicated by chylous ascites were shown in the literature due to that well known causes. By that time there were not any cases that showed vaginal delivery complicated by incidental chylous ascites. In the present study we reported a 19 year-old women who had chylous ascites after vaginal delivery without any potential causes of the disease. She was consultated by general surgeon and explorative laparotomy was decided which did not show any etiologic reason for ascites. After all she was referred to us for further investigation and treatment of the chyle. She was treated conservatively and the drain was removed on post-op 6th. Despite the detailed investigation there was not found any causes that explain the ascites and the increased intra-abdominal pressure during second stage of delivery was thought to be most potential cause of chylous ascites. Patient was discharged on post-op 10 and on long follow up of 6 and 12 months after delivery she was doing well and had","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45828242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bowel Preparation for Flexible Sigmoidoscopy: Is a Phosphate Enema Sufficient? 柔性乙状结肠镜下的肠道准备:磷酸盐灌肠是否足够?
Pub Date : 2019-09-17 DOI: 10.33552/AJGH.2019.01.000513
M. Abdeldayem, Michael N Frempong, J. Waterman, Melanie Fuller, P. Haray
Background Bowel preparation is crucial to undertake flexible sigmoidoscopy, as poor views of the bowel mucosa can result in an inadequate examination and the need for further investigations. Endoscopists develop personal preferences and patient tolerance and side effects also have an impact on the choice of the bowel preparation used. Endoscopy units also have different protocols which can be administered orally or rectally. Aim
背景:在进行乙状结肠镜检查时,肠道准备是至关重要的,因为肠道黏膜的不良视图可能导致检查不充分,需要进一步检查。内窥镜医师的个人偏好和患者的耐受性以及副作用也会影响所使用的肠道准备的选择。内窥镜检查单位也有不同的方案,可以口服或直肠给药。目的
{"title":"Bowel Preparation for Flexible Sigmoidoscopy: Is a Phosphate Enema Sufficient?","authors":"M. Abdeldayem, Michael N Frempong, J. Waterman, Melanie Fuller, P. Haray","doi":"10.33552/AJGH.2019.01.000513","DOIUrl":"https://doi.org/10.33552/AJGH.2019.01.000513","url":null,"abstract":"Background Bowel preparation is crucial to undertake flexible sigmoidoscopy, as poor views of the bowel mucosa can result in an inadequate examination and the need for further investigations. Endoscopists develop personal preferences and patient tolerance and side effects also have an impact on the choice of the bowel preparation used. Endoscopy units also have different protocols which can be administered orally or rectally. Aim","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42269124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spilled Gallstones during Laparoscopic Cholecystectomy: Case Series and Review of Literature 腹腔镜胆囊切除术中胆囊结石外溢:病例系列及文献回顾
Pub Date : 2019-08-27 DOI: 10.33552/ajgh.2019.01.000512
M. T. Kyaw
Patient is a 76-year-old man with past medical history of hypertension, type 2 diabetes mellitus, hyperlipidemia, coronary artery disease, chronic renal insufficiency, alcoholic cirrhosis who was diagnosed with cholelithiasis in 2015. He subsequently developed cholecystitis, which was complicated by choledocholithiasis with cholangitis, requiring ERCP with biliary stent, followed by laparoscopic cholecystectomy. There was no documentation of spilled stones or any other complication during the surgery. Two years after laparoscopic cholecystectomy [2], patient presented with abdominal distention and pain predominantly in the epigastric region, not related to food. Abdomen CT scan showed subphrenic fluid collection extending along right abdominal wall with two to three calcified spilled gallstones. During the hospital course, patient developed fever, leukocytosis and tachycardia. He was diagnosed with sepsis and treated for suspected pneumonia. Patient underwent interventional radiology (IR) guided drainage for multiloculated complex hepatic fluid. Eight hundred milliliters of greenish viscous fluid were aspirated [3]. Culture from intraperitoneal aspiration is negative. IR failed to remove gallstone after dilating the access. Patient underwent an extensive peritoneal washout and perihepatic fluid collection resolved Figure 1. Figure 1: 76 years old Male with Subphrenic Heterogenous Fluid Collection extending Right Abdominal Wall.
患者为76岁男性,既往有高血压、2型糖尿病、高脂血症、冠状动脉疾病、慢性肾功能不全、酒精性肝硬化病史,2015年被诊断为胆结石。随后,他患上了胆囊炎,并发胆总管结石和胆管炎,需要用胆道支架进行ERCP,然后进行腹腔镜胆囊切除术。手术过程中没有任何结石溢出或任何其他并发症的记录。腹腔镜胆囊切除术后两年,患者出现腹胀和疼痛,主要发生在上腹部,与食物无关。腹部CT扫描显示膈下积液沿右腹壁延伸,有两到三个钙化溢出的胆结石。在住院期间,患者出现发烧、白细胞增多和心动过速。他被诊断为败血症,并接受了疑似肺炎的治疗。患者接受了介入放射学(IR)引导的多房复杂肝液引流术。抽吸了800毫升绿色粘稠液体[3]。腹膜内抽吸培养为阴性。IR在扩张入路后未能清除胆囊结石。患者接受了广泛的腹膜冲洗,肝周积液收集如图1所示。图1:76岁男性,膈下异源性积液延伸至右腹壁。
{"title":"Spilled Gallstones during Laparoscopic Cholecystectomy: Case Series and Review of Literature","authors":"M. T. Kyaw","doi":"10.33552/ajgh.2019.01.000512","DOIUrl":"https://doi.org/10.33552/ajgh.2019.01.000512","url":null,"abstract":"Patient is a 76-year-old man with past medical history of hypertension, type 2 diabetes mellitus, hyperlipidemia, coronary artery disease, chronic renal insufficiency, alcoholic cirrhosis who was diagnosed with cholelithiasis in 2015. He subsequently developed cholecystitis, which was complicated by choledocholithiasis with cholangitis, requiring ERCP with biliary stent, followed by laparoscopic cholecystectomy. There was no documentation of spilled stones or any other complication during the surgery. Two years after laparoscopic cholecystectomy [2], patient presented with abdominal distention and pain predominantly in the epigastric region, not related to food. Abdomen CT scan showed subphrenic fluid collection extending along right abdominal wall with two to three calcified spilled gallstones. During the hospital course, patient developed fever, leukocytosis and tachycardia. He was diagnosed with sepsis and treated for suspected pneumonia. Patient underwent interventional radiology (IR) guided drainage for multiloculated complex hepatic fluid. Eight hundred milliliters of greenish viscous fluid were aspirated [3]. Culture from intraperitoneal aspiration is negative. IR failed to remove gallstone after dilating the access. Patient underwent an extensive peritoneal washout and perihepatic fluid collection resolved Figure 1. Figure 1: 76 years old Male with Subphrenic Heterogenous Fluid Collection extending Right Abdominal Wall.","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45795047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tia Leading to the Diagnosis Amelanotic Metastatic Gastric Melanoma Tia导致无色素转移性胃黑色素瘤的诊断
Pub Date : 2019-08-13 DOI: 10.33552/ajgh.2019.01.000511
Scott T Larson
Shaheer Siddiqui1, Tarun Jain2, Zhenjian Cai3 and Scott Larson4* 1Department of Gastroenterology & Hepatology, University of Texas, McGovern School of Medicine, USA 2Department of Resident Internal Medicine, University of Texas, McGovern School of Medicine, USA 3Department of Assistant Professor Pathology, University of Texas, McGovern School of Medicine, USA 4Department of Assistant Professor Gastroenterology &Hepatology, University of Texas, McGovern School of Medicine, USA
Shaheer Siddiqui1、Tarun Jain2、Zhenjian Cai3和Scott Larson4*1得克萨斯大学胃肠病与肝病系、美国麦戈文医学院2得克萨斯大学住院内科、美国麦戈文医学院3得克萨斯大学病理学助理教授系、,美国4美国得克萨斯大学麦戈文医学院胃肠病与肝病学助理教授
{"title":"Tia Leading to the Diagnosis Amelanotic Metastatic Gastric Melanoma","authors":"Scott T Larson","doi":"10.33552/ajgh.2019.01.000511","DOIUrl":"https://doi.org/10.33552/ajgh.2019.01.000511","url":null,"abstract":"Shaheer Siddiqui1, Tarun Jain2, Zhenjian Cai3 and Scott Larson4* 1Department of Gastroenterology & Hepatology, University of Texas, McGovern School of Medicine, USA 2Department of Resident Internal Medicine, University of Texas, McGovern School of Medicine, USA 3Department of Assistant Professor Pathology, University of Texas, McGovern School of Medicine, USA 4Department of Assistant Professor Gastroenterology &Hepatology, University of Texas, McGovern School of Medicine, USA","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42201853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coexistence of Crohn’s Disease and Systemic Lupus Erythematosus with Lupus Nephritis : About Two Cases 克罗恩病与系统性红斑狼疮并发狼疮肾炎2例
Pub Date : 2019-08-09 DOI: 10.33552/ajgh.2019.01.000510
M. Somaï
Systemic lupus erythematosus (SLE) is a chronic multisystem inflammatory disease, known as a prototype for autoimmune disease [1,2]. It is usually associated with other autoimmune and dysimmune diseases. Inflammatory bowel disease (IBD) is one of the specific dysimmune diseases of the intestine with extraintestinal involvements and with environmental factors and genetic predisposition [3]. IBD is a chronic recurrent disease comprised of two major phenotypes, Crohn’s disease (CD) and ulcerative colitis [4]. The coexistence of SLE and CD in the same patient is extremely rare (<0.4%) [5]. Even rarer is the association between lupus nephritis (LN) and CD, with only two cases reported to date [6,7]. A review study corroborated that SLE was associated with comorbid CD (OR 2.23) [8]. We communicate herein two cases of patients, ones with SLE who was diagnosed CD colitis and the other with CD who was diagnosed SLE. Case presentation 1
系统性红斑狼疮(SLE)是一种慢性多系统炎性疾病,被认为是自身免疫性疾病的原型[1,2]。它通常与其他自身免疫和免疫障碍疾病有关。炎症性肠病(IBD)是一种特殊的肠外免疫系统疾病,与环境因素和遗传易感性有关。IBD是一种慢性复发性疾病,包括两种主要表型,克罗恩病(CD)和溃疡性结肠炎。SLE和CD在同一患者中共存极为罕见(<0.4%)。狼疮性肾炎(LN)与CD之间的关联更为罕见,迄今仅有2例报道[6,7]。一项回顾性研究证实SLE与合并症CD (OR 2.23)相关。我们在此交流两例患者,一例SLE患者被诊断为乳糜泻结肠炎,另一例乳糜泻患者被诊断为SLE。案例展示1
{"title":"Coexistence of Crohn’s Disease and Systemic Lupus Erythematosus with Lupus Nephritis : About Two Cases","authors":"M. Somaï","doi":"10.33552/ajgh.2019.01.000510","DOIUrl":"https://doi.org/10.33552/ajgh.2019.01.000510","url":null,"abstract":"Systemic lupus erythematosus (SLE) is a chronic multisystem inflammatory disease, known as a prototype for autoimmune disease [1,2]. It is usually associated with other autoimmune and dysimmune diseases. Inflammatory bowel disease (IBD) is one of the specific dysimmune diseases of the intestine with extraintestinal involvements and with environmental factors and genetic predisposition [3]. IBD is a chronic recurrent disease comprised of two major phenotypes, Crohn’s disease (CD) and ulcerative colitis [4]. The coexistence of SLE and CD in the same patient is extremely rare (<0.4%) [5]. Even rarer is the association between lupus nephritis (LN) and CD, with only two cases reported to date [6,7]. A review study corroborated that SLE was associated with comorbid CD (OR 2.23) [8]. We communicate herein two cases of patients, ones with SLE who was diagnosed CD colitis and the other with CD who was diagnosed SLE. Case presentation 1","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44240148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of Serum Adiponectin with Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 非酒精性脂肪肝患者血清脂联素与肝纤维化的相关性
Pub Date : 2019-07-18 DOI: 10.33552/AJGH.2019.01.000509
Golam Mustafa, Harun-or Rashid, Shahinul Alam, Mahbubul Alam, R. Mustafa, N. Ahmad
Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder characterized by excessive triglyceride accumulation in the hepatocytes. It is a hepatic manifestation of metabolic syndrome [1]. The prevalence of NAFLD in India above 20 years age was 18.9% [2]. The prevalence of NAFLD increased with increased age. Obesity, diabetes mellitus (DM), insulin resistance (IR) are predisposing factors for NAFLD. Although NAFLD is more common in subject with obesity and diabetes mellitus (DM), it also occurs in lean and non-diabetic subject [3,4,5]. Non obese was 25.6% among NAFLD patient in Bangladesh. About 53.1 % of non-obese NAFLD cases were NASH [6].
非酒精性脂肪性肝病(NAFLD)是一种以肝细胞中甘油三酯过量积累为特征的代谢性疾病。它是代谢综合征[1]的肝脏表现。印度20岁以上NAFLD患病率为18.9%。NAFLD的患病率随着年龄的增长而增加。肥胖、糖尿病(DM)、胰岛素抵抗(IR)是NAFLD的易感因素。虽然NAFLD在肥胖和糖尿病(DM)患者中更为常见,但在瘦弱和非糖尿病患者中也有发生[3,4,5]。孟加拉国NAFLD患者中非肥胖占25.6%。约53.1%的非肥胖NAFLD患者为NASH患者。
{"title":"Correlation of Serum Adiponectin with Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease","authors":"Golam Mustafa, Harun-or Rashid, Shahinul Alam, Mahbubul Alam, R. Mustafa, N. Ahmad","doi":"10.33552/AJGH.2019.01.000509","DOIUrl":"https://doi.org/10.33552/AJGH.2019.01.000509","url":null,"abstract":"Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder characterized by excessive triglyceride accumulation in the hepatocytes. It is a hepatic manifestation of metabolic syndrome [1]. The prevalence of NAFLD in India above 20 years age was 18.9% [2]. The prevalence of NAFLD increased with increased age. Obesity, diabetes mellitus (DM), insulin resistance (IR) are predisposing factors for NAFLD. Although NAFLD is more common in subject with obesity and diabetes mellitus (DM), it also occurs in lean and non-diabetic subject [3,4,5]. Non obese was 25.6% among NAFLD patient in Bangladesh. About 53.1 % of non-obese NAFLD cases were NASH [6].","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46852716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levofloxacin Based H. Pylori Eradication Therapy, should we Give it A better Consideration? 以左氧氟沙星为基础的幽门螺杆菌根除治疗,我们是否应该给予更好的考虑?
Pub Date : 2019-06-19 DOI: 10.33552/ajgh.2019.01.000508
Ahmad Hassan
Helicobacter pylori (H. pylori) infection, one of the most common bacterial infections, affects approximately 50% of the world’s population [1]. H. pylori infection is a major cause of gastritis, gastric and duodenal ulcers, mucosal associated lymphoid tissue, and gastric cancer [2]. H. pylori eradication treatment has been proven to improve gastric inflammation, promote ulcer healing, and reduce the incidence of gastric cancer [3,4]. Furthermore, a “test-and-treat” approach is advocated for detecting and eradicating H. pylori in patients with dyspeptic symptoms but low gastric cancer risk [5].
幽门螺杆菌(h.p ylori)感染是最常见的细菌感染之一,影响着世界上大约50%的人口。幽门螺杆菌感染是胃炎、胃和十二指肠溃疡、粘膜相关淋巴组织和胃癌的主要原因。幽门螺杆菌根除治疗已被证明可以改善胃炎症,促进溃疡愈合,降低胃癌的发病率[3,4]。此外,对于有消化不良症状但胃癌风险较低的患者,提倡采用“检测与治疗”的方法来检测和根除幽门螺杆菌。
{"title":"Levofloxacin Based H. Pylori Eradication Therapy, should we Give it A better Consideration?","authors":"Ahmad Hassan","doi":"10.33552/ajgh.2019.01.000508","DOIUrl":"https://doi.org/10.33552/ajgh.2019.01.000508","url":null,"abstract":"Helicobacter pylori (H. pylori) infection, one of the most common bacterial infections, affects approximately 50% of the world’s population [1]. H. pylori infection is a major cause of gastritis, gastric and duodenal ulcers, mucosal associated lymphoid tissue, and gastric cancer [2]. H. pylori eradication treatment has been proven to improve gastric inflammation, promote ulcer healing, and reduce the incidence of gastric cancer [3,4]. Furthermore, a “test-and-treat” approach is advocated for detecting and eradicating H. pylori in patients with dyspeptic symptoms but low gastric cancer risk [5].","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43749882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paneth Cell Metaplasia: An Ominous Finding 面板细胞化生:一个不祥的发现
Pub Date : 2019-05-28 DOI: 10.33552/AJGH.2019.01.000507
Parivash Badar, Syed Mikhail Zaidi
Discussion regarding the nature of paneth cell metaplasia has become increasingly popular over the last decade with respect to certain breakthrough studies emphasizing on the relationship between Inflammatory Bowel Disease and PCM. However, the incident of isolated paneth cell metaplasia in an otherwise unremarkable mucosa and asymptomatic patient has not been extensively studied [1]. A strong correlation has been established between distal PCM and the presence of newly diagnosed IBD in children [2]. Further it was emphasized that even though the presence of distal PCM is a marker for the presence of IBD in an individual, the presence of proximal PCM was seen to be nonspecific sign in adults however it has been established that repair and regeneration may be the most potent stimuli for PCM [3][4].
在过去的十年里,关于泛肠细胞化生性质的讨论越来越受欢迎,因为一些突破性研究强调了炎症性肠病和PCM之间的关系。然而,在其他不明显的粘膜和无症状患者中,孤立的潘氏细胞化生的事件尚未得到广泛研究[1]。远端PCM与儿童新诊断的IBD之间存在着强烈的相关性[2]。此外,有人强调,尽管远端PCM的存在是个体IBD存在的标志,但近端PCM的存在在成人中被视为非特异性体征,但已经确定修复和再生可能是PCM最有力的刺激[3][4]。
{"title":"Paneth Cell Metaplasia: An Ominous Finding","authors":"Parivash Badar, Syed Mikhail Zaidi","doi":"10.33552/AJGH.2019.01.000507","DOIUrl":"https://doi.org/10.33552/AJGH.2019.01.000507","url":null,"abstract":"Discussion regarding the nature of paneth cell metaplasia has become increasingly popular over the last decade with respect to certain breakthrough studies emphasizing on the relationship between Inflammatory Bowel Disease and PCM. However, the incident of isolated paneth cell metaplasia in an otherwise unremarkable mucosa and asymptomatic patient has not been extensively studied [1]. A strong correlation has been established between distal PCM and the presence of newly diagnosed IBD in children [2]. Further it was emphasized that even though the presence of distal PCM is a marker for the presence of IBD in an individual, the presence of proximal PCM was seen to be nonspecific sign in adults however it has been established that repair and regeneration may be the most potent stimuli for PCM [3][4].","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43555430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Hepatitis-Like Syndrome Revealing Hashimoto Thyroiditis 揭示桥本甲状腺炎的急性肝炎样综合征
Pub Date : 2019-01-12 DOI: 10.33552/AJGH.2019.01.000506
S. Bouomrani, M. Guermazi, S. Yahyaoui, H. Nouma
Introduction: Disturbances of hepatic biologic tests are not uncommon during hypothyroidism but classically refer to rhabdomyolysis. More rarely, moderate and reversible chronic cholestasis or hypertransamenaemia can be observed. Acute hepatitis-like syndrome remains exceptional. Case report: 30-year-old patient with no pathological medical history was referred to us by her family doctor for suspicion of acute viral hepatitis: ASAT at 4N and ALAT at 3N, asthenia, abdominal pain, and vomiting evolving for three days in an epidemic context of hepatitis A. The clinical examination noted bradycardia at 58/min and macroglossia. Hepatic tests confirmed hepatocellular necrosis without cholestasis or hepatocellular insufficiency: ASAT at 355IU/l (8N), ALAT at 243IU/l (6N), total bilirubin at 14.80μmol/l, GGT at 15IU/l and PT at 100%. The serodiagnostics of viral hepatitis A, B and C, and specific liver autoantibodies were negative. Thyroid assessment revealed deep primary hypothyroidism with TSH at 182.7μmol/ml. The evolution under hormonal substitution treatment was favorable with disappearance of the clinical complaints and normalization of the liver tests with the normalization of the TSH. Conclusion: Acute hepatocellular necrosis remains an exceptional presentation of hypothyroidism. His diagnosis is not always easy, especially since in the autoimmune context of Hashimoto’s thyroiditis, the association with true autoimmune hepatitis can be discussed. As well as a thyroid disorder associated with chronic viral hepatitis. A screening of the thyroid function is thus justified in front of any hepatocellular necrosis that is not proven.
简介:肝生物学检查紊乱在甲状腺功能减退时并不少见,但通常指的是横纹肌溶解。更罕见的是,可以观察到中度和可逆的慢性胆汁淤积或高血凝血症。急性肝炎样综合征仍属例外。病例报告:患者30岁,无病理病史,经家庭医生转诊,疑似急性病毒性肝炎:ASAT 4N, ALAT 3N,乏力,腹痛,呕吐3天,呈甲型肝炎流行背景。临床检查发现心动过缓58/分,舌大。肝脏检查证实肝细胞坏死,无胆汁淤积或肝细胞功能不全:ASAT为355IU/l (8N), ALAT为243IU/l (6N),总胆红素14.80μmol/l, GGT为15IU/l, PT为100%。病毒性甲型、乙型和丙型肝炎的血清诊断和特异性肝脏自身抗体均为阴性。甲状腺检查显示深度原发性甲状腺功能减退,TSH为182.7μmol/ml。激素替代治疗的进展是有利的,临床主诉消失,肝脏检查随着TSH的正常化而正常化。结论:急性肝细胞坏死是甲减的一种特殊表现。他的诊断并不总是容易的,特别是在自身免疫性桥本甲状腺炎的情况下,与真正的自身免疫性肝炎的关系可以讨论。以及与慢性病毒性肝炎相关的甲状腺疾病。因此,在任何未经证实的肝细胞坏死前进行甲状腺功能筛查是合理的。
{"title":"Acute Hepatitis-Like Syndrome Revealing Hashimoto Thyroiditis","authors":"S. Bouomrani, M. Guermazi, S. Yahyaoui, H. Nouma","doi":"10.33552/AJGH.2019.01.000506","DOIUrl":"https://doi.org/10.33552/AJGH.2019.01.000506","url":null,"abstract":"Introduction: Disturbances of hepatic biologic tests are not uncommon during hypothyroidism but classically refer to rhabdomyolysis. More rarely, moderate and reversible chronic cholestasis or hypertransamenaemia can be observed. Acute hepatitis-like syndrome remains exceptional. Case report: 30-year-old patient with no pathological medical history was referred to us by her family doctor for suspicion of acute viral hepatitis: ASAT at 4N and ALAT at 3N, asthenia, abdominal pain, and vomiting evolving for three days in an epidemic context of hepatitis A. The clinical examination noted bradycardia at 58/min and macroglossia. Hepatic tests confirmed hepatocellular necrosis without cholestasis or hepatocellular insufficiency: ASAT at 355IU/l (8N), ALAT at 243IU/l (6N), total bilirubin at 14.80μmol/l, GGT at 15IU/l and PT at 100%. The serodiagnostics of viral hepatitis A, B and C, and specific liver autoantibodies were negative. Thyroid assessment revealed deep primary hypothyroidism with TSH at 182.7μmol/ml. The evolution under hormonal substitution treatment was favorable with disappearance of the clinical complaints and normalization of the liver tests with the normalization of the TSH. Conclusion: Acute hepatocellular necrosis remains an exceptional presentation of hypothyroidism. His diagnosis is not always easy, especially since in the autoimmune context of Hashimoto’s thyroiditis, the association with true autoimmune hepatitis can be discussed. As well as a thyroid disorder associated with chronic viral hepatitis. A screening of the thyroid function is thus justified in front of any hepatocellular necrosis that is not proven.","PeriodicalId":72038,"journal":{"name":"Academic journal of gastroenterology & hepatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42707357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Academic journal of gastroenterology & hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1